We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Murphy Oil
MUR
$5.43B
| $1.38M | 0.01% |
59,290
+12,867
| +28% | +$262K |
|
|
ZEUS
677
DELISTED
Olympic Steel
ZEUS
| $1.38M | 0.01% |
46,947
-22,545
| -32% | -$711K |
|
678
Alcoa
AA
$11.6B
| $1.37M | 0.01% |
+37,212
| New | +$1.35M |
|
679
Bankunited
BKU
$3.4B
| $1.36M | 0.01% |
31,814
+12,293
| +63% | +$561K |
|
680
Vail Resorts
MTN
$5.39B
| $1.35M | 0.01% |
+4,280
| New | +$1.36M |
|
681
LyondellBasell Industries
LYB
$19B
| $1.35M | 0.01% |
+13,107
| New | +$1.42M |
|
|
BVH
682
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $1.34M | 0.01% |
+74,667
| New | +$1.46M |
|
|
GDEN
683
DELISTED
Golden Entertainment
GDEN
| $1.34M | 0.01% |
+29,957
| New | +$1.15M |
|
|
CSTR
684
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.33M | 0.01% |
65,085
+13,497
| +26% | +$271K |
|
685
Savara
SVRA
$1.13B
| $1.33M | 0.01% |
782,582
-5,068
| -0.6% | -$9.12K |
|
686
Academy Sports + Outdoors
ASO
$3.06B
| $1.31M | 0.01% |
+31,896
| New | +$1.12M |
|
687
Sanmina
SANM
$10.8B
| $1.31M | 0.01% |
33,639
+1,796
| +6% | +$74.1K |
|
688
Avient
AVNT
$3.42B
| $1.31M | 0.01% |
26,577
-123,358
| -82% | -$6.24M |
|
|
RJET
689
Republic Airways Holdings
RJET
$827M
| $1.31M | 0.01% |
9,338
-19,115
| -67% | -$3.08M |
|
690
Virtu Financial
VIRT
$5.15B
| $1.3M | 0.01% |
47,205
+38,179
| +423% | +$1.14M |
|
|
EPZM
691
DELISTED
Epizyme, Inc
EPZM
| $1.3M | 0.01% |
+156,890
| New | +$1.32M |
|
692
BeyondSpring
BYSI
$46.9M
| $1.3M | 0.01% |
124,808
+20,489
| +20% | +$216K |
|
|
ZYNE
693
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.3M | 0.01% |
245,018
+130,579
| +114% | +$628K |
|
694
Amalgamated Financial
AMAL
$1.47B
| $1.29M | 0.01% |
82,853
+4,055
| +5% | +$65.7K |
|
|
CLR
695
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $1.29M | 0.01% |
33,986
-146,119
| -81% | -$4.54M |
|
696
Xencor
XNCR
$1.47B
| $1.29M | 0.01% |
+37,273
| New | +$1.48M |
|
697
Dine Brands
DIN
$445M
| $1.28M | 0.01% |
14,301
-9,469
| -40% | -$876K |
|
698
Thor Industries
THO
$4.11B
| $1.27M | 0.01% |
+11,284
| New | +$1.43M |
|
|
QADA
699
DELISTED
QAD Inc.
QADA
| $1.27M | 0.01% |
14,646
-34,183
| -70% | -$2.49M |
|
700
Mirum Pharmaceuticals
MIRM
$6.94B
| $1.26M | 0.01% |
72,733
+49,394
| +212% | +$885K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.